Cargando…
Molecular Epidemiology and Evolution of European Bat Lyssavirus 2
Bat rabies cases in Europe are mainly attributed to two lyssaviruses, namely European Bat Lyssavirus 1 (EBLV-1) and European Bat Lyssavirus 2 (EBLV-2). Prior to the death of a bat worker in Finland in 1985, very few bat rabies cases were reported. Enhanced surveillance in the two subsequent years (1...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796105/ https://www.ncbi.nlm.nih.gov/pubmed/29303971 http://dx.doi.org/10.3390/ijms19010156 |
_version_ | 1783297434120617984 |
---|---|
author | McElhinney, Lorraine M. Marston, Denise A. Wise, Emma L. Freuling, Conrad M. Bourhy, Hervé Zanoni, Reto Moldal, Torfinn Kooi, Engbert A. Neubauer-Juric, Antonie Nokireki, Tiina Müller, Thomas Fooks, Anthony R. |
author_facet | McElhinney, Lorraine M. Marston, Denise A. Wise, Emma L. Freuling, Conrad M. Bourhy, Hervé Zanoni, Reto Moldal, Torfinn Kooi, Engbert A. Neubauer-Juric, Antonie Nokireki, Tiina Müller, Thomas Fooks, Anthony R. |
author_sort | McElhinney, Lorraine M. |
collection | PubMed |
description | Bat rabies cases in Europe are mainly attributed to two lyssaviruses, namely European Bat Lyssavirus 1 (EBLV-1) and European Bat Lyssavirus 2 (EBLV-2). Prior to the death of a bat worker in Finland in 1985, very few bat rabies cases were reported. Enhanced surveillance in the two subsequent years (1986–1987) identified 263 cases (more than a fifth of all reported cases to date). Between 1977 and 2016, 1183 cases of bat rabies were reported, with the vast majority (>97%) being attributed to EBLV-1. In contrast, there have been only 39 suspected cases of EBLV-2, of which 34 have been confirmed by virus typing and presently restricted to just two bat species; Myotis daubentonii and Myotis dasycneme. The limited number of EBLV-2 cases in Europe prompted the establishment of a network of European reference laboratories to collate all available viruses and data. Despite the relatively low number of EBLV-2 cases, a large amount of anomalous data has been published in the scientific literature, which we have here reviewed and clarified. In this review, 29 EBLV-2 full genome sequences have been analysed to further our understanding of the diversity and molecular evolution of EBLV-2 in Europe. Analysis of the 29 complete EBLV-2 genome sequences clearly corroborated geographical relationships with all EBLV-2 sequences clustering at the country level irrespective of the gene studied. Further geographical clustering was also observed at a local level. There are high levels of homogeneity within the EBLV-2 species with nucleotide identities ranging from 95.5–100% and amino acid identities between 98.7% and 100%, despite the widespread distribution of the isolates both geographically and chronologically. The mean substitution rate for EBLV-2 across the five concatenated genes was 1.65 × 10(−5), and evolutionary clock analysis confirms the slow evolution of EBLV-2 both between and within countries in Europe. This is further supported by the first detailed EBLV-2 intra-roost genomic analysis whereby a relatively high sequence homogeneity was found across the genomes of three EBLV-2 isolates obtained several years apart (2007, 2008, and 2014) from M. daubentonii at the same site (Stokesay Castle, Shropshire, UK). |
format | Online Article Text |
id | pubmed-5796105 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-57961052018-02-09 Molecular Epidemiology and Evolution of European Bat Lyssavirus 2 McElhinney, Lorraine M. Marston, Denise A. Wise, Emma L. Freuling, Conrad M. Bourhy, Hervé Zanoni, Reto Moldal, Torfinn Kooi, Engbert A. Neubauer-Juric, Antonie Nokireki, Tiina Müller, Thomas Fooks, Anthony R. Int J Mol Sci Review Bat rabies cases in Europe are mainly attributed to two lyssaviruses, namely European Bat Lyssavirus 1 (EBLV-1) and European Bat Lyssavirus 2 (EBLV-2). Prior to the death of a bat worker in Finland in 1985, very few bat rabies cases were reported. Enhanced surveillance in the two subsequent years (1986–1987) identified 263 cases (more than a fifth of all reported cases to date). Between 1977 and 2016, 1183 cases of bat rabies were reported, with the vast majority (>97%) being attributed to EBLV-1. In contrast, there have been only 39 suspected cases of EBLV-2, of which 34 have been confirmed by virus typing and presently restricted to just two bat species; Myotis daubentonii and Myotis dasycneme. The limited number of EBLV-2 cases in Europe prompted the establishment of a network of European reference laboratories to collate all available viruses and data. Despite the relatively low number of EBLV-2 cases, a large amount of anomalous data has been published in the scientific literature, which we have here reviewed and clarified. In this review, 29 EBLV-2 full genome sequences have been analysed to further our understanding of the diversity and molecular evolution of EBLV-2 in Europe. Analysis of the 29 complete EBLV-2 genome sequences clearly corroborated geographical relationships with all EBLV-2 sequences clustering at the country level irrespective of the gene studied. Further geographical clustering was also observed at a local level. There are high levels of homogeneity within the EBLV-2 species with nucleotide identities ranging from 95.5–100% and amino acid identities between 98.7% and 100%, despite the widespread distribution of the isolates both geographically and chronologically. The mean substitution rate for EBLV-2 across the five concatenated genes was 1.65 × 10(−5), and evolutionary clock analysis confirms the slow evolution of EBLV-2 both between and within countries in Europe. This is further supported by the first detailed EBLV-2 intra-roost genomic analysis whereby a relatively high sequence homogeneity was found across the genomes of three EBLV-2 isolates obtained several years apart (2007, 2008, and 2014) from M. daubentonii at the same site (Stokesay Castle, Shropshire, UK). MDPI 2018-01-05 /pmc/articles/PMC5796105/ /pubmed/29303971 http://dx.doi.org/10.3390/ijms19010156 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review McElhinney, Lorraine M. Marston, Denise A. Wise, Emma L. Freuling, Conrad M. Bourhy, Hervé Zanoni, Reto Moldal, Torfinn Kooi, Engbert A. Neubauer-Juric, Antonie Nokireki, Tiina Müller, Thomas Fooks, Anthony R. Molecular Epidemiology and Evolution of European Bat Lyssavirus 2 |
title | Molecular Epidemiology and Evolution of European Bat Lyssavirus 2 |
title_full | Molecular Epidemiology and Evolution of European Bat Lyssavirus 2 |
title_fullStr | Molecular Epidemiology and Evolution of European Bat Lyssavirus 2 |
title_full_unstemmed | Molecular Epidemiology and Evolution of European Bat Lyssavirus 2 |
title_short | Molecular Epidemiology and Evolution of European Bat Lyssavirus 2 |
title_sort | molecular epidemiology and evolution of european bat lyssavirus 2 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796105/ https://www.ncbi.nlm.nih.gov/pubmed/29303971 http://dx.doi.org/10.3390/ijms19010156 |
work_keys_str_mv | AT mcelhinneylorrainem molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 AT marstondenisea molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 AT wiseemmal molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 AT freulingconradm molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 AT bourhyherve molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 AT zanonireto molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 AT moldaltorfinn molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 AT kooiengberta molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 AT neubauerjuricantonie molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 AT nokirekitiina molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 AT mullerthomas molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 AT fooksanthonyr molecularepidemiologyandevolutionofeuropeanbatlyssavirus2 |